A randomized double-blind phase II study evaluating the role of maintenance therapy with cabozantinib in high-grade uterine sarcoma after stabilization or response to doxorubicin ± ifosfamide following surgery or in metastatic first line treatment (EORTC62113)
Nom du journal : Int J Gynecol Cancer
Année : 2020
Volume : 30
Page de départ : 1633
Page de fin : 1637